Algert Global LLC Blueprint Medicines Corp Transaction History

Algert Global LLC

  • $3.01 Billion
  • Q2 2024

A detailed history of Algert Global LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Algert Global LLC holds 65,540 shares of BPMC stock, worth $5.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
65,540
Previous 36,210 81.0%
Holding current value
$5.9 Million
Previous $3.44 Million 105.65%
% of portfolio
0.23%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $2.5 Million - $3.19 Million
29,330 Added 81.0%
65,540 $7.06 Million
Q1 2024

May 14, 2024
BUY
$73.17 - $99.79 $898,527 - $1.23 Million
12,280 Added 51.32%
36,210 $3.44 Million
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $789,961 - $1.67 Million
17,970 Added 301.51%
23,930 $2.21 Million
Q3 2023

Nov 13, 2023
BUY
$46.9 - $66.0 $279,524 - $393,360
5,960 New
5,960 $299,000
Q2 2022

Aug 15, 2022
BUY
$45.23 - $70.15 $47,491 - $73,657
1,050 Added 9.75%
11,819 $597,000
Q1 2022

May 16, 2022
BUY
$54.1 - $110.08 $78,823 - $160,386
1,457 Added 15.65%
10,769 $688,000
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $602,634 - $741,640
6,394 Added 219.12%
9,312 $997,000
Q3 2021

Nov 15, 2021
BUY
$80.98 - $109.47 $236,299 - $319,433
2,918 New
2,918 $300,000
Q3 2020

Nov 16, 2020
SELL
$66.45 - $92.7 $718,523 - $1 Million
-10,813 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$57.09 - $79.27 $853,495 - $1.19 Million
-14,950 Reduced 58.03%
10,813 $843,000
Q1 2020

May 13, 2020
BUY
$48.11 - $82.22 $1.24 Million - $2.12 Million
25,763 New
25,763 $1.51 Million
Q4 2018

Feb 01, 2019
SELL
$45.57 - $74.26 $260,751 - $424,915
-5,722 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$58.91 - $78.32 $337,083 - $448,147
5,722 New
5,722 $447,000

Others Institutions Holding BPMC

# of Institutions
340
Shares Held
62M
Call Options Held
987K
Put Options Held
578K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.37B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email